H-Thr-OBzl·Hemioxalate CAS:86088-59-7

Hauv kev tsim cov peptide, H-Thr-OBzl·Hemioxalate ua haujlwm ua ib qho tseem ceeb tiv thaiv amino acid derivative uas dhau los ntawm kev tiv thaiv thiab kev ua haujlwm rau kev sib txuas nrog lwm cov amino acids los tsim cov saw peptide. Kev saib xyuas zoo rau cov xwm txheej ntawm cov tshuaj tiv thaiv thiab cov txheej txheem ntxuav yog qhov tsim nyog los tswj cov tshuaj kom zoo thiab tsim cov khoom peptide zoo. Cov kws tshawb fawb thiab cov kws tshawb fawb txog tshuaj koom ua ke H-Thr-OBzl·Hemioxalate rau hauv lawv cov txheej txheem tsim los tsim cov kab ke peptide tshwj xeeb nrog kev ua haujlwm ntawm lub cev lossis lub peev xwm kho mob. Kev huv si thiab kev ruaj khov ntawm cov tshuaj yog qhov tseem ceeb rau kev ua kom muaj txiaj ntsig zoo hauv kev tsim cov peptide, pab txhawb rau kev tsim cov tshuaj tshiab thiab cov tshuaj bioactive. Ntxiv mus, H-Thr-OBzl·Hemioxalate qhov sib xws nrog cov txheej txheem solid-phase synthesis ua rau nws muaj kev koom ua ke zoo rau hauv cov peptide synthesizers, ua kom yooj yim rau kev tsim cov peptides thiab peptide tsev qiv ntawv rau kev tshawb pom tshuaj thiab kev siv tshawb fawb. Nws lub luag haujlwm hauv kev tsim cov qauv peptide sib txawv ua rau nws yog ib qho cuab yeej muaj txiaj ntsig rau kev daws teeb meem ntau yam kev cov nyom biomedical thiab tshawb nrhiav txoj hauv kev tshiab rau kev kho mob. Zuag qhia tag nrho, H-Thr-OBzl·Hemioxalate qhov tseem ceeb hauv kev tsim cov peptide nthuav dav thoob plaws kev tshawb fawb txog tshuaj, biotechnology, thiab tshuaj lom neeg, qhov twg nws txuas ntxiv pab txhawb kev tsim cov tshuaj kho mob tshiab thiab biopharmaceuticals, tsav kev nce qib hauv kev kho mob thiab kev tshawb fawb txog lub neej.